Related Experiment Video
Updated: Aug 7, 2026
09:25
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma
Published on: October 14, 2016
Telangiectatic osteosarcoma: a clinicopathologic analysis of 14 cases
1Department of Pathology, Beijing Jishuitan Hospital, Beijing 100035, China.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology
|December 12, 2002
Summary
Telangiectatic osteosarcoma is a rare bone cancer. Early diagnosis is challenging, and its aggressive nature significantly impacts patient prognosis, often leading to metastasis and poor outcomes.
Area of Science:
- Orthopedic Oncology
- Skeletal Pathology
- Cancer Research
Background:
- Telangiectatic osteosarcoma (TOS) is a rare subtype of osteosarcoma.
- It presents unique clinicopathologic characteristics.
- Understanding its features is crucial for effective management.
Purpose of the Study:
- To investigate the clinicopathologic characteristics of telangiectatic osteosarcoma.
- To evaluate the prognosis associated with this bone cancer subtype.
- To identify factors influencing patient outcomes.
Main Methods:
- Retrospective review of clinical and pathological data from 14 TOS cases.
- Analysis of radiographic, gross, and microscopic findings.
- Follow-up data for 12 patients to assess survival and metastasis.
Main Results:
- Predominantly affects young males (mean age 23), often in lower extremities.
- Radiographically presents as a purely osteolytic lesion with extensive bone destruction.
- Histologically shows cystic cavities with anaplastic cells and minimal osteoid formation.
- High rate of pulmonary metastasis (7/12), with a poor survival rate (6/7 deaths).
Conclusions:
- Early diagnosis of telangiectatic osteosarcoma is difficult.
- The highly malignant nature of TOS significantly impacts prognosis.
- Aggressive treatment and further research are needed to improve outcomes.
